TransEnterix Completes Sale of the Senhance™ Surgical System in Germany
Chosen to establish program in robotic general and gynecologic surgery
St. Marien-Krankenhaus Siegen, a large multi-specialty hospital, has purchased the Senhance Surgical System to establish a robotic surgical program that will initially be focused on general and gynecologic surgery.
"We chose the Senhance to bring robotic surgical assistance to the
treatment of our patients," said Professor Dr.
This press release includes statements relating to the Senhance™
Surgical Robotic System and our current regulatory and commercialization
plans for this product. These statements and other statements regarding
our future plans and goals constitute "forward-looking statements"
within the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934, and are intended to
qualify for the safe harbor from liability established by the Private
Securities Litigation Reform Act of 1995. Such statements are subject to
risks and uncertainties that are often difficult to predict, are beyond
our control and which may cause results to differ materially from
expectations and include whether the Senhance System uses a unique
combination of advanced technology and responsible economics. For a
discussion of the risks and uncertainties associated with
(For EU) Conrad Harrington, +44 (0)20 3178 8914
News Provided by Acquire Media